# Phase 3 Myocardial Infarction trials recruiting: 21 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials in phase 3 for Myocardial Infarction that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 Myocardial Infarction trials: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/myocardial-infarction

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07938411 | A Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial Infarction | Novartis Pharmaceuticals | Phase 3 | Not yet recruiting | Myocardial Infarction | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938411) |
| March 17, 2026 | NCT07478003 | Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial | Sponsor not shown (see the record) | Phase 3 | Recruiting | STEMI - ST Elevation Myocardial Infarction | 5,204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07478003) |
| March 3, 2026 | NCT07445737 | Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction | Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | STEMI - ST Elevation Myocardial Infarction | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07445737) |
| February 2, 2026 | NCT07381803 | The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 3 | Recruiting | Zhejiang University | 2,804 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07381803) |
| January 6, 2026 | NCT07320625 | Efficacy of Montelukast on STEMl Patients | Shanghai Zhongshan Hospital | Phase 3 | Recruiting | Myocardial Infarction (MI) | 512 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07320625) |
| December 24, 2025 | NCT07301034 | A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a... | Novo Nordisk A/S | Phase 3 | Recruiting | Myocardial Infarction | 332 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07301034) |
| December 22, 2025 | NCT07297589 | Epicardial Cardiac Fat-CT (EPIC-CT) | Instituto Mexicano del Seguro Social | Phase 3 | Recruiting | STEMI - ST Elevation Myocardial Infarction, Epicardial Fat | 136 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07297589) |
| December 2, 2025 | NCT07257198 | Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone | Montreal Heart Institute | Phase 3 | Recruiting | NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI), Myocardial Infarction | 2,570 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07257198) |
| November 14, 2025 | NCT07229248 | DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial | National Institute of Cardiovascular Diseases, Pakistan | Phase 3 | Recruiting | STEMI (ST Elevation MI) | 496 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07229248) |
| September 16, 2025 | NCT07174414 | Cilostazol for Prevention of Recurrent Stroke Trial | Stanford University | Phase 3 | Recruiting | Stroke Recurrence, Myocardial Infarction, Vascular Death, Ischemic Stroke, TIA (Transient Ischemic Attack), Stroke... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07174414) |
| August 22, 2025 | NCT07136012 | OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events | Amgen | Phase 3 | Recruiting | Cardiovascular Disease | 11,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07136012) |
| July 7, 2025 | NCT07052799 | Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy | Chinese University of Hong Kong | Phase 3 | Recruiting | Myocardial Infarction (MI), Cardiovascular Events, Post Polypectomy Bleeding in Antiplatelet Patients | 2,514 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07052799) |
| February 26, 2025 | NCT06847568 | The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and... | Ain Shams University | Phase 3 | Recruiting | ST Segment Elevation Myocardial Infarction (STEMI), No Reflow Phenomenon | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06847568) |
| December 19, 2024 | NCT06742567 | Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction | National Institute of Cardiovascular Diseases, Pakistan | Phase 3 | Recruiting | Acute Myocardial Infarction of Anterior Wall, Left Ventricular Thrombus, Prophylaxis | 472 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06742567) |
| November 26, 2024 | NCT06704685 | A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in... | Xiangya Hospital of Central South University | Phase 3 | Not yet recruiting | ST-segment Elevation Myocardial Infarction (STEMI) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06704685) |
| December 18, 2023 | NCT06174753 | Dapagliflozin in STEMI | Ottawa Heart Institute Research Corporation | Phase 3 | Recruiting | ST Elevation Myocardial Infarction, Myocardial Infarction | 256 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06174753) |
| March 10, 2023 | NCT05764057 | DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction | Assistance Publique - Hôpitaux de Paris | Phase 3 | Recruiting | AMI, STEMI, NSTEMI, Left Ventricular Dysfunction | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05764057) |
| October 13, 2022 | NCT05577988 | Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency... | Assistance Publique - Hôpitaux de Paris | Phase 3 | Recruiting | MYOCARDIAL INFARCTION | 2,468 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05577988) |
| July 27, 2022 | NCT05476991 | Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis | Assistance Publique - Hôpitaux de Paris | Phase 3 | Recruiting | Stroke, Stroke, Ischemic, Atherosclerosis, Myocardial Infarction, Coronary Syndrome, TIA, Cardiac Disease, Cerebral... | 2,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05476991) |
| March 1, 2021 | NCT04774159 | Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk | Population Health Research Institute | Phase 3 | Recruiting | Peripheral Arterial Disease, Atherosclerosis of Extremities, Inflammation | 6,150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04774159) |
| June 26, 2019 | NCT03998319 | A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients. | University of Sydney | Phase 3 | Recruiting | STEMI, Elevated IMR (\>32) | 445 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03998319) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assistance Publique - Hôpitaux de Paris | 4 |
| National Institute of Cardiovascular Diseases, Pakistan | 2 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 1 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 1 |
| Population Health Research Institute | 1 |
| Ain Shams University | 1 |
| Instituto Mexicano del Seguro Social | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| Stanford University | 1 |
| Chinese University of Hong Kong | 1 |
| Montreal Heart Institute | 1 |
| University of Sydney | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Xiangya Hospital of Central South University | 1 |

## By country

| Country | Trials |
| --- | --- |
| France | 4 |
| Canada | 4 |
| Australia | 3 |
| China | 3 |
| United States | 3 |
| Denmark | 2 |
| Netherlands | 2 |
| Switzerland | 2 |
| Pakistan | 2 |
| Austria | 1 |
| Italy | 1 |
| Spain | 1 |
| Belgium | 1 |
| Brazil | 1 |
| Ecuador | 1 |
| Germany | 1 |
| United Kingdom | 1 |
| Egypt | 1 |
| Mexico | 1 |
| Hong Kong | 1 |
| New Zealand | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Mediators in the United States](https://specstream.ai/data/businesses/mediators/united-states)
- [Laboratories in the United States](https://specstream.ai/data/businesses/laboratories/united-states)
- [Importers in the United States](https://specstream.ai/data/businesses/importers/united-states)
- [Hardware and fastener manufacturers in the United States](https://specstream.ai/data/businesses/hardware-and-fastener-manufacturers/united-states)
- [Food and beverage consultants in the United States](https://specstream.ai/data/businesses/food-and-beverage-consultants/united-states)
- [Environmental services in the United States](https://specstream.ai/data/businesses/environmental-services/united-states)
